Current through December 12, 2024
Section 639.Sec. 1.10 - NEW1. A person or public or private facility shall not operate or provide the services of a facility for treatment with narcotics unless the person or facility holds a license to administer opioid agonist treatment medication issued by the Board pursuant to this section.2. A person or public or private facility may apply to the Board for a license to administer opioid agonist treatment medication by submitting an application to the Board on a form prescribed by the Board. The Board shall issue such a license if the applicant meets the requirements sets forth in subsection 3 and pays the fee required by NAC 639.220.3. An applicant for a license pursuant to subsection 2 must: (a) Be certified by the Substance Abuse and Mental Health Services Administration of the United States Department of Health and Human Services pursuant to 42 C.F.R. § 8.11;(b) Hold a license issued by the Division of Public and Behavioral Health of the Department of Health and Human Services pursuant to NAC 449.154 to 449.15485, inclusive, to operate a facility for treatment with narcotics;(c) Be certified by the Division of Public and Behavioral Health of the Department of Health and Human Services pursuant to NRS 458.025; and(d) Ensure that each practitioner who dispenses opioid agonist treatment medication at the facility is registered with the Board pursuant to NRS 453.231 and the Drug Enforcement Administration of the United States Department of Justice to dispense controlled substances.4. Any license issued pursuant to this section is a revocable privilege and a holder of such a license does not acquire any vested right in such a license.5. Each dispensing practitioner practicing at a facility for treatment with narcotics shall, to the extent required by 42 C.F.R. § 2.36, obtain informed consent for the reporting of information to the computerized program to track prescriptions for controlled substances established pursuant to NRS 453.162.Nev. Admin. Code § 639.Sec. 1.10
Added to NAC by Bd. of Pharmacy by R196-22A, eff. 9/18/2023NRS 453.221, 639.070, 639.2177